Skip to content
HealthTech Series B Founded 2020

Triomics

Triomics provides clinical research and clinical trial tracking software, offering an end-to-end platform for running clinical trials that unifies the workflows of clinical care and clinical research. The platform eliminates operational inefficiencies in data collection, patient recruitment, and other labor-intensive tasks involved in clinical research. Founded in 2020 and headquartered in San Francisco, United…

📍 San Francisco, United States · Life Sciences Tech,

Funding snapshot

Last roundSeries B
Amount$22M
Date28 May 2026
Total raised$51M
Team size1

About

Triomics provides clinical research and clinical trial tracking software, offering an end-to-end platform for running clinical trials that unifies the workflows of clinical care and clinical research. The platform eliminates operational inefficiencies in data collection, patient recruitment, and other labor-intensive tasks involved in clinical research. Founded in 2020 and headquartered in San Francisco, United States, Triomics has raised approximately $50.9M in Series B funding from investors including Y Combinator, Nexus Venture Partners, General Catalyst, Lightspeed Venture Partners, and Battery Ventures. The company leverages generative AI to automate clinical trial operations, including patient screening, data abstraction, and regulatory documentation, helping research institutions and pharmaceutical companies accelerate trial timelines and reduce administrative burden while maintaining compliance with clinical research standards.

Business model

Life Sciences Tech > Research & Development > Clinical Trials > Diversified,

Y Combinator Batches > 2021 > Winter

Team background

College Wise > IIT Roorkee

Institutional investors

Y Combinator Nexus Venture Partners General Catalyst Lightspeed Battery Ventures Lightspeed Venture Partners

Latest coverage

No articles yet.

Raising like Triomics?

Analyze your pitch deck before your next raise.

Analyze My Deck →